Martha Morrell is CHIEF MEDICAL OFFICER of NeuroPace Inc. Currently has a direct ownership of 80,563 shares of NPCE, which is worth approximately $1.04 Million. The most recent transaction as insider was on Jan 30, 2024, when has been sold 11,262 shares (Common Stock) at a price of $15.1 per share, resulting in proceeds of $170,056. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.6K
70.18% 3M change
32.0% 12M change
Total Value Held $1.04 Million

Martha Morrell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 30 2024
SELL
Open market or private sale
$170,056 $15.1 p/Share
11,262 Reduced 10.31%
97,937 Common Stock
Jan 25 2024
SELL
Open market or private sale
$15 $15.0 p/Share
1 Reduced 0.0%
109,199 Common Stock
Jan 24 2024
SELL
Open market or private sale
$12,429 $15.03 p/Share
827 Reduced 0.75%
109,200 Common Stock
Jan 22 2024
SELL
Payment of exercise price or tax liability
$3,917 $14.84 p/Share
264 Reduced 0.35%
75,076 Common Stock
Dec 27 2023
SELL
Open market or private sale
$134,596 $10.12 p/Share
13,300 Reduced 10.78%
110,027 Common Stock
Dec 26 2023
SELL
Open market or private sale
$1,020 $10.0 p/Share
102 Reduced 0.08%
123,327 Common Stock
Dec 20 2023
SELL
Open market or private sale
$27,682 $10.14 p/Share
2,730 Reduced 2.16%
123,429 Common Stock
Dec 06 2023
SELL
Open market or private sale
$89,800 $8.16 p/Share
11,005 Reduced 8.02%
126,159 Common Stock
Dec 03 2023
SELL
Payment of exercise price or tax liability
$11,596 $8.9 p/Share
1,303 Reduced 1.7%
75,340 Common Stock
Oct 22 2023
SELL
Payment of exercise price or tax liability
$1,589 $6.88 p/Share
231 Reduced 0.3%
76,643 Common Stock
Sep 03 2023
SELL
Payment of exercise price or tax liability
$11,626 $8.93 p/Share
1,302 Reduced 1.67%
76,874 Common Stock
Jul 22 2023
SELL
Payment of exercise price or tax liability
$954 $4.13 p/Share
231 Reduced 0.29%
78,176 Common Stock
Jun 03 2023
SELL
Payment of exercise price or tax liability
$5,355 $4.11 p/Share
1,303 Reduced 1.63%
78,407 Common Stock
Apr 22 2023
SELL
Payment of exercise price or tax liability
$981 $4.25 p/Share
231 Reduced 0.29%
79,710 Common Stock
Mar 03 2023
SELL
Payment of exercise price or tax liability
$21,184 $4.1 p/Share
5,167 Reduced 6.07%
79,941 Common Stock
Feb 20 2023
BUY
Grant, award, or other acquisition
-
80,000 Added 36.84%
137,164 Common Stock
Jan 22 2023
SELL
Payment of exercise price or tax liability
$786 $2.98 p/Share
264 Reduced 0.31%
85,108 Common Stock
Oct 22 2022
SELL
Payment of exercise price or tax liability
$703 $3.02 p/Share
233 Reduced 0.27%
85,372 Common Stock
Oct 07 2022
BUY
Exercise of conversion of derivative security
$17 $0.03 p/Share
576 Added 1.0%
57,164 Common Stock
Jul 22 2022
SELL
Payment of exercise price or tax liability
$1,282 $5.55 p/Share
231 Reduced 0.27%
85,605 Common Stock
Apr 22 2022
SELL
Payment of exercise price or tax liability
$7,704 $8.32 p/Share
926 Reduced 1.07%
85,836 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
46,760 Added 45.25%
56,588 Common Stock
Jun 04 2021
BUY
Grant, award, or other acquisition
-
8,181 Added 45.76%
9,699 Common Stock
MM

Martha Morrell

CHIEF MEDICAL OFFICER
Mountain View, CA

Track Institutional and Insider Activities on NPCE

Follow NeuroPace Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NPCE shares.

Notify only if

Insider Trading

Get notified when an Neuro Pace Inc insider buys or sells NPCE shares.

Notify only if

News

Receive news related to NeuroPace Inc

Track Activities on NPCE